Medipower -M Cash Flow Conversion Efficiency

Latest as of March 2026: 0.025x

Medipower -M cash flow conversion efficiency. Based on the latest financial reports, Medipower -M (MDPR) has a cash flow conversion efficiency ratio of 0.025x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA5.21 Million ≈ $13.96K USD) by net assets (ILA205.71 Million ≈ $551.51K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Medipower -M (2012–2025)

Cash flow conversion efficiency of Medipower -M from 2012 to 2025. This chart illustrates how Medipower -M's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Medipower -M stock price for real-time trading data and today's change.

Medipower -M Cash Flow Conversion Ratio Explained

Medipower -M cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Medipower -M Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medipower -M ranked by their cash flow conversion efficiency. Also see market value of Medipower -M for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Sinkang Industries Co Ltd
TW:2032
-0.040x
Super Dragon Technology Co Ltd
TW:9955
0.036x
Wspierania Przedsiebiorczosci
WAR:PTW
0.003x
ad pepper media International N.V
XETRA:APM
0.095x
Milestone Pharmaceuticals Inc
NASDAQ:MIST
-0.479x
Wentel Engineering Holdings Berhad
KLSE:0298
0.039x
EN Shoham Business Ltd
TA:SHOM
-0.068x
Haemato AG
HM:HAEK
N/A

Annual Cash Flow Conversion Efficiency for Medipower -M (2012–2025)

The table below shows the annual cash flow conversion efficiency of Medipower -M from 2012 to 2025. Review Medipower -M free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ILA167.55 Million
≈ $449.19K
ILA17.80 Million
≈ $47.72K
0.106x +1.53%
2024-12-31 ILA151.53 Million
≈ $406.26K
ILA15.86 Million
≈ $42.51K
0.105x +23.26%
2023-12-31 ILA141.36 Million
≈ $378.98K
ILA12.00 Million
≈ $32.17K
0.085x -13.19%
2022-12-31 ILA132.20 Million
≈ $354.43K
ILA12.93 Million
≈ $34.66K
0.098x +14.46%
2021-12-31 ILA111.22 Million
≈ $298.18K
ILA9.50 Million
≈ $25.47K
0.085x -18.18%
2020-12-31 ILA80.93 Million
≈ $216.96K
ILA8.45 Million
≈ $22.65K
0.104x +14.85%
2019-12-31 ILA78.17 Million
≈ $209.58K
ILA7.11 Million
≈ $19.05K
0.091x +26.40%
2018-12-31 ILA75.40 Million
≈ $202.14K
ILA5.42 Million
≈ $14.54K
0.072x +28.41%
2017-12-31 ILA74.57 Million
≈ $199.93K
ILA4.18 Million
≈ $11.20K
0.056x -19.30%
2016-12-31 ILA52.26 Million
≈ $140.10K
ILA3.63 Million
≈ $9.72K
0.069x +295.73%
2015-12-31 ILA34.84 Million
≈ $93.40K
ILA611.00K
≈ $1.64K
0.018x -52.60%
2014-12-31 ILA36.97 Million
≈ $99.12K
ILA1.37 Million
≈ $3.67K
0.037x +17.41%
2013-12-31 ILA37.92 Million
≈ $101.65K
ILA1.20 Million
≈ $3.20K
0.032x +301.78%
2012-12-31 ILA125.74 Million
≈ $337.09K
ILA-1.96 Million
≈ $-5.27K
-0.016x --

About Medipower -M

TA:MDPR Israel Real Estate Services
Market Cap
$64.97 Million
ILA24.23 Billion ILA
Market Cap Rank
#20636 Global
#265 in Israel
Share Price
ILA473.90
Change (1 day)
-0.02%
52-Week Range
ILA461.00 - ILA709.80
All Time High
ILA852.30
About

Medipower (Overseas) Public Co. Limited, together with its subsidiaries, operates as a commercial real estate company in the United States, Canada, and Bulgaria. It engages in the acquisition, rental, redevelopment, operation, and management of commercial income-generating real estate, primarily retail properties. The company was incorporated in 2001 and is based in Nicosia, Cyprus.